Loading clinical trials...
Loading clinical trials...
A Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of CAT-354
Conditions
Interventions
Placebo
CAT-354 1 mg/kg
+2 more
Locations
41
Australia
St. Vincents Hospital, Thoracic Medicine Unit
Darlinghurst, New South Wales, Australia
Respiratory Medicine Department, Mater Adult Hospital,
South Brisbane, Queensland, Australia
Princess Alexandria Hospital, Dept of Respiratory Medicine
Woolloongabba, Queensland, Australia
Eastern Clinical Research Unit
Box Hill, Victoria, Australia
Monash Medical Centre, Dept Respiratory Medicine.
Clayton, Victoria, Australia
Dep of Respiratory & Sleep Medicine, Western Hospital
Footscray, Victoria, Australia
Start Date
January 1, 2008
Primary Completion Date
July 1, 2008
Completion Date
July 1, 2008
Last Updated
January 31, 2017
NCT07219173
NCT07486401
NCT02327897
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
MedImmune LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions